ATYR
aTyr Pharma
ATYR
ATYR
108 hedge funds and large institutions have $336M invested in aTyr Pharma in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+22
Holders Change %
+25.58%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
51
Increased
25
Reduced
24
Closed
29
Calls
$5.88M
Puts
$3.81M
Net Calls
+$2.07M
Net Calls Change
+$3.61M
Top Buyers
1 |
BlackRock
New York
|
$29.3M |
2 |
Geode Capital Management
Boston,
Massachusetts
|
$10.6M |
3 |
State Street
Boston,
Massachusetts
|
$6.29M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
$23.6M |
5 |
Invesco
Atlanta,
Georgia
|
$3.03M |
Top Sellers
1 |
Point72 Asset Management
Stamford,
Connecticut
|
$5.01M |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.29M |
3 |
ABG
Ally Bridge Group
New York
|
$1.46M |
4 |
Goldman Sachs
New York
|
$184K |
5 |
![]()
Marshall Wace
London,
United Kingdom
|
$2.59M |